BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Østensen M, Lockshin M, Doria A, Valesini G, Meroni P, Gordon C, Brucato A, Tincani A. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology (Oxford). 2008;47 Suppl 3:iii28-iii31. [PMID: 18504282 DOI: 10.1093/rheumatology/ken168] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Carnovale C, Tombetti E, Battini V, Mazhar F, Radice S, Nivuori M, Negro E, Tamanini S, Brucato A. Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review.Front Pharmacol. 2020;11:612259. [PMID: 33551814 DOI: 10.3389/fphar.2020.612259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Silva CA, Cocuzza M, Borba EF, Bonfá E. Cutting-Edge Issues in Autoimmune Orchitis. Clinic Rev Allerg Immunol 2012;42:256-63. [DOI: 10.1007/s12016-011-8281-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
3 Flint J, Panchal S, Hurrell A, van de Venne M, Gayed M, Schreiber K, Arthanari S, Cunningham J, Flanders L, Moore L, Crossley A, Purushotham N, Desai A, Piper M, Nisar M, Khamashta M, Williams D, Gordon C, Giles I; on behalf of the BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part II: analgesics and other drugs used in rheumatology practice: Table 1. Rheumatology 2016;55:1698-702. [DOI: 10.1093/rheumatology/kev405] [Cited by in Crossref: 78] [Cited by in F6Publishing: 48] [Article Influence: 15.6] [Reference Citation Analysis]
4 Silva CA, Bonfa E, Østensen M. Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res 2010;62:1682-90. [DOI: 10.1002/acr.20323] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
5 Fischer-Betz RE, Schneider M. [Biologics during pregnancy and breast--feeding]. Z Rheumatol 2010;69:780-7. [PMID: 21063826 DOI: 10.1007/s00393-010-0640-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
6 Kim M, Rostas S, Gabardi S. Mycophenolate fetal toxicity and risk evaluation and mitigation strategies. Am J Transplant. 2013;13:1383-1389. [PMID: 23617812 DOI: 10.1111/ajt.12238] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 6.1] [Reference Citation Analysis]
7 Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 2009;61:451-85. [PMID: 19493586 DOI: 10.1016/j.jaad.2009.03.027] [Cited by in Crossref: 360] [Cited by in F6Publishing: 233] [Article Influence: 30.0] [Reference Citation Analysis]
8 Alijotas-reig J, Esteve-valverde E, Ferrer-oliveras R, Llurba E, Gris JM. Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review. Clinic Rev Allerg Immunol 2017;53:40-53. [DOI: 10.1007/s12016-016-8596-x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 17.5] [Reference Citation Analysis]
9 Senabre-Gallego JM, Santos-Ramírez C, Santos-Soler G, Salas-Heredia E, Sánchez-Barrioluengo M, Barber X, Rosas J; AIRE-MB group. Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis. Patient Prefer Adherence 2013;7:961-72. [PMID: 24101863 DOI: 10.2147/PPA.S33109] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
10 Sangle SR, Lutalo PM, Davies RJ, Khamashta MA, D’Cruz DP. B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases. J Autoimmun. 2013;43:55-59. [PMID: 23608146 DOI: 10.1016/j.jaut.2013.03.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
11 Colla L, Diena D, Rossetti M, Manzione AM, Marozio L, Benedetto C, Biancone L. Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era. J Nephrol 2018;31:361-83. [DOI: 10.1007/s40620-018-0477-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
12 Elliott AB, Chakravarty EF. Management of rheumatic diseases during pregnancy. Postgrad Med 2010;122:213-21. [PMID: 20463432 DOI: 10.3810/pgm.2010.05.2160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Al-Mogairen S. Does Abatacept Induce Testicular Toxicity? Arch Rheumatol 2020;35:220-5. [PMID: 32851371 DOI: 10.46497/ArchRheumatol.2020.7164] [Reference Citation Analysis]
14 Day CJ, Lipkin GW, Savage COS. Lupus nephritis and pregnancy in the 21st century. Nephrology Dialysis Transplantation 2008;24:344-7. [DOI: 10.1093/ndt/gfn651] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
15 Rump JA, Schönborn H. [Conception and course of eight pregnancies in five women on TNF blocker etanercept treatment]. Z Rheumatol. 2010;69:903-909. [PMID: 20532789 DOI: 10.1007/s00393-010-0652-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
16 Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 2013;27:435-47. [PMID: 24238698 DOI: 10.1016/j.berh.2013.07.005] [Cited by in Crossref: 89] [Cited by in F6Publishing: 53] [Article Influence: 12.7] [Reference Citation Analysis]
17 Amissah-Arthur MB, Gordon C. Contemporary treatment of systemic lupus erythematosus: an update for clinicians. Ther Adv Chronic Dis 2010;1:163-75. [PMID: 23251736 DOI: 10.1177/2040622310380100] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
18 Flint J, Panchal S, Hurrell A, van de Venne M, Gayed M, Schreiber K, Arthanari S, Cunningham J, Flanders L, Moore L, Crossley A, Purushotham N, Desai A, Piper M, Nisar M, Khamashta M, Williams D, Gordon C, Giles I; BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 2016;55:1693-7. [PMID: 26750124 DOI: 10.1093/rheumatology/kev404] [Cited by in Crossref: 219] [Cited by in F6Publishing: 149] [Article Influence: 43.8] [Reference Citation Analysis]
19 Andreoli L, Bazzani C, Taraborelli M, Reggia R, Lojacono A, Brucato A, Meroni PL, Tincani A. Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. Autoimmun Rev 2010;10:51-4. [PMID: 20696283 DOI: 10.1016/j.autrev.2010.08.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
20 Lateef A, Petri M. Management of pregnancy in systemic lupus erythematosus. Nat Rev Rheumatol. 2012;8:710-718. [PMID: 22907290 DOI: 10.1038/nrrheum.2012.133] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
21 Verstappen SM, King Y, Watson KD, Symmons DP, Hyrich KL. Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2011;70:823-826. [PMID: 21362710 DOI: 10.1136/ard.2010.140822] [Cited by in Crossref: 125] [Cited by in F6Publishing: 93] [Article Influence: 12.5] [Reference Citation Analysis]
22 Busse M, Campe KJ, Nowak D, Schumacher A, Plenagl S, Langwisch S, Tiegs G, Reinhold A, Zenclussen AC. IL-10 producing B cells rescue mouse fetuses from inflammation-driven fetal death and are able to modulate T cell immune responses. Sci Rep 2019;9:9335. [PMID: 31249364 DOI: 10.1038/s41598-019-45860-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
23 Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol 2010;149:423-32.e1-2. [PMID: 20042178 DOI: 10.1016/j.ajo.2009.09.026] [Cited by in Crossref: 150] [Cited by in F6Publishing: 98] [Article Influence: 12.5] [Reference Citation Analysis]
24 Ton E, Tekstra J, Hellmann PM, Nuver-Zwart IH, Bijlsma JW. Safety of rituximab therapy during twins’ pregnancy. Rheumatology (Oxford). 2011;50:806-808. [PMID: 21177333 DOI: 10.1093/rheumatology/keq403] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
25 Gouveia IF, Silva JR, Santos C, Carvalho C. Maternal and fetal outcomes of pregnancy in chronic kidney disease: diagnostic challenges, surveillance and treatment throughout the spectrum of kidney disease. J Bras Nefrol 2021;43:88-102. [PMID: 33460427 DOI: 10.1590/2175-8239-JBN-2020-0055] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Mormile I, Granata F, Punziano A, de Paulis A, Rossi FW. Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It? Biomedicines 2021;9:132. [PMID: 33535377 DOI: 10.3390/biomedicines9020132] [Reference Citation Analysis]
27 Jenner F, IJpma A, Cleary M, Heijsman D, Narcisi R, van der Spek PJ, Kremer A, van Weeren R, Brama P, van Osch GJ. Differential gene expression of the intermediate and outer interzone layers of developing articular cartilage in murine embryos. Stem Cells Dev 2014;23:1883-98. [PMID: 24738827 DOI: 10.1089/scd.2013.0235] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
28 Lazzaroni MG, Dall’ara F, Fredi M, Nalli C, Reggia R, Lojacono A, Ramazzotto F, Zatti S, Andreoli L, Tincani A. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. Journal of Autoimmunity 2016;74:106-17. [DOI: 10.1016/j.jaut.2016.06.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 9.2] [Reference Citation Analysis]
29 Paziana K, Del Monaco M, Cardonick E, Moritz M, Keller M, Smith B, Coscia L, Armenti V. Ciclosporin use during pregnancy. Drug Saf. 2013;36:279-294. [PMID: 23516008 DOI: 10.1007/s40264-013-0034-x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 39] [Article Influence: 9.3] [Reference Citation Analysis]
30 Kane SV, Acquah LA. Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy. Am J Gastroenterol 2009;104:228-33. [DOI: 10.1038/ajg.2008.71] [Cited by in Crossref: 169] [Cited by in F6Publishing: 124] [Article Influence: 13.0] [Reference Citation Analysis]
31 González-rivera TC, Mccune J. Mycophenolate mofetil for the induction and maintenance treatment of lupus nephritis. Immunotherapy 2011;3:1431-40. [DOI: 10.2217/imt.11.148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Rouster-Stevens KA, Morgan GA, Wang D, Pachman LM. Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis. Arthritis Care Res (Hoboken) 2010;62:1446-51. [PMID: 20521307 DOI: 10.1002/acr.20269] [Cited by in Crossref: 62] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
33 Perrotta K, Kiernan E, Bandoli G, Manaster R, Chambers C. Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series. Rheumatol Adv Pract 2021;5:rkaa074. [PMID: 33521513 DOI: 10.1093/rap/rkaa074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
34 Pagnoux C, Mahendira D, Laskin CA. Fertility and pregnancy in vasculitis. Best Pract Res Clin Rheumatol 2013;27:79-94. [PMID: 23507059 DOI: 10.1016/j.berh.2013.02.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
35 Thomas RM, Colon A, Motaparthi K. Rituximab in autoimmune pemphigoid diseases: Indications, optimized regimens, and practice gaps. Clin Dermatol 2020;38:384-96. [PMID: 32563354 DOI: 10.1016/j.clindermatol.2019.07.023] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Harris C, Marin J, Beaulieu MC. Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report. BMC Nephrol 2018;19:152. [PMID: 29954345 DOI: 10.1186/s12882-018-0949-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
37 Vinet E, Pineau C, Gordon C, Clarke AE, Bernatsky S. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum 2009;61:587-92. [PMID: 19404999 DOI: 10.1002/art.24462] [Cited by in Crossref: 59] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
38 Reino JG, Loza E, Andreu JL, Balsa A, Batlle E, Cañete JD, Collantes Estévez E, Fernández Carballido C, Fernández Sueiro JL, García de Vicuña R, González-álvaro I, González Fernández C, Juanola X, Linares LF, Marenco JL, Martín Mola E, Moreno Ramos M, Mulero Mendoza J, Muñoz Fernández S, Queiro R, Richi Alberti P, Sanz J, Tornero Molina J, Zarco Montejo P, Carmona L. Consenso SER sobre la gestión de riesgo del tratamiento con terapias biológicas en pacientes con enfermedades reumáticas. Reumatología Clínica 2011;7:284-98. [DOI: 10.1016/j.reuma.2011.05.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
39 Aneman I, Pienaar D, Suvakov S, Simic TP, Garovic VD, McClements L. Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia. Front Immunol 2020;11:1864. [PMID: 33013837 DOI: 10.3389/fimmu.2020.01864] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
40 Tornero Molina J, Sanmartí Sala R, Rodríguez Valverde V, Martín Mola E, Marenco de la Fuente JL, González Álvaro I, Muñoz Fernández S, Gómez-reino Carnota J, Carreño Pérez L, Batlle Gualda E, Balsa Criado A, Andreu JL, Álvaro-gracia JM, Martínez López JA, Loza Santamaría E. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide. Reumatología Clínica 2010;6:23-36. [DOI: 10.1016/j.reuma.2009.10.006] [Cited by in Crossref: 67] [Cited by in F6Publishing: 30] [Article Influence: 6.1] [Reference Citation Analysis]
41 Meyer KC, Decker C, Baughman R. Toxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases. Clin Chest Med 2010;31:565-88. [PMID: 20692548 DOI: 10.1016/j.ccm.2010.05.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
42 Porres-Aguilar M, Figueroa-Casas JB, Porres-Muñoz M, Elliott CG. A 38-year-old pregnant woman with hemoptysis and acute renal failure. Microscopic polyangiitis. Respiration 2011;82:60-4. [PMID: 21555869 DOI: 10.1159/000327174] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
43 Nagata M, Kaneko K, Kohno C, Mishima S, Okazaki Y, Murashima A. A case of successful pregnancy following multidrug treatment including rituximab and intravenous immunoglobulin for primary antiphospholipid antibody syndrome refractory to conventional treatment. Mod Rheumatol Case Rep 2020;4:47-50. [PMID: 33086951 DOI: 10.1080/24725625.2019.1648633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Hyrich KL, Verstappen SM. Biologic therapies and pregnancy: the story so far. Rheumatology (Oxford). 2014;53:1377-1385. [PMID: 24352337 DOI: 10.1093/rheumatology/ket409] [Cited by in Crossref: 73] [Cited by in F6Publishing: 55] [Article Influence: 9.1] [Reference Citation Analysis]
45 Rabelo-Júnior CN, Freire de Carvalho J, Lopes Gallinaro A, Bonfá E, Cocuzza M, Saito O, Silva CA. Primary antiphospholipid syndrome: morphofunctional penile abnormalities with normal sperm analysis. Lupus 2012;21:251-6. [PMID: 22004973 DOI: 10.1177/0961203311422715] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
46 Ng SW, Mahadevan U. Management of inflammatory bowel disease in pregnancy. Expert Rev Clin Immunol. 2013;9:161-173; quiz 174. [PMID: 23390947 DOI: 10.1586/eci.12.103] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
47 Karim MY, D’cruz DP. Practical management of lupus nephritis in pregnancy and the puerperium. Expert Review of Clinical Pharmacology 2014;3:777-84. [DOI: 10.1586/ecp.10.55] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
48 Mena-vazquez N. Safety of biologic therapies during pregnancy in women with rheumatic disease. WJR 2015;5:82. [DOI: 10.5499/wjr.v5.i2.82] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Kasi PM, Tawbi HA, Oddis CV, Kulkarni HS. Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective. Crit Care 2012;16:231. [PMID: 22967460 DOI: 10.1186/cc11304] [Cited by in Crossref: 81] [Cited by in F6Publishing: 57] [Article Influence: 9.0] [Reference Citation Analysis]
50 Uchiyama E, Papaliodis GN, Lobo AM, Sobrin L. Side-effects of anti-inflammatory therapy in uveitis. Semin Ophthalmol 2014;29:456-67. [PMID: 25325874 DOI: 10.3109/08820538.2014.959203] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
51 Gatto M, Iaccarino L, Canova M, Zen M, Nalotto L, Ramonda R, Punzi L, Doria A. Pregnancy and vasculitis: A systematic review of the literature. Autoimmunity Reviews 2012;11:A447-59. [DOI: 10.1016/j.autrev.2011.11.019] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]